Technical Analysis for ETX - E-Therapeutics Plc

Grade Last Price % Change Price Change
F 20.85 0.00% 0.00
ETX closed unchanged on Friday, April 16, 2021, on 16 percent of normal volume.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Strong Up Down Flat
Historical ETX trend table...

Date Alert Name Type % Chg
20 DMA Resistance Bearish 0.00%
Multiple of Ten Bullish Other 0.00%
Slingshot Bearish Bearish Swing Setup 0.00%
Lower Bollinger Band Walk Weakness 0.00%
Multiple of Ten Bullish Other 0.00%
Slingshot Bearish Bearish Swing Setup 1.96%
Lower Bollinger Band Walk Weakness 1.96%
Multiple of Ten Bullish Other 1.96%
Outside Day Range Expansion 1.96%
Lower Bollinger Band Touch Weakness 1.96%
Older End-of-Day Signals for ETX ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

E-Therapeutics Plc Description

e-Therapeutics plc is a United Kingdom-based drug discovery and development company. The Company's discovery platform is based on the network of pharmacology and chemical biology. The Company operates in the business segment of drug discovery and development. The Company applies its platform to the discovery of new drug candidates. The therapeutic focus of the Company's discovery activity is in immuno-oncology, addressing drug resistance in targeted cancer therapies and antivirals. The Company generates a range of preclinical stage assets, including ETX1153c, a functionally resistance-less antibiotic; ETS2300, telomerase inhibition in anti-cancer; ETS3100, small molecule antiTNFα; ETS2400, in Hedgehog pathway inhibition, and ETS5200, which delivers a range of spectrum antivirals. The Company has completed a Phase IIb study of a drug candidate for depressive disorder, ETS6103, as well as Phase I clinical trials in cancer for ETS2101.


Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Health Network Target Chemical Hedge Clinic Cancer Nature Oncology Clinical Trial Biology Resistance Itn Therapies Drug Discovery Antibiotic Pharmacology Erase Biocides

Is ETX a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 26.8
52 Week Low 10.6459
Average Volume 681,418
200-Day Moving Average 16.95
50-Day Moving Average 23.03
20-Day Moving Average 21.90
10-Day Moving Average 20.95
Average True Range 1.95
ADX 28.56
+DI 8.47
-DI 12.21
Chandelier Exit (Long, 3 ATRs ) 20.16
Chandelier Exit (Short, 3 ATRs ) 24.84
Upper Bollinger Band 24.51
Lower Bollinger Band 19.28
Percent B (%b) 0.3
BandWidth 23.91
MACD Line -0.67
MACD Signal Line -0.54
MACD Histogram -0.122
Fundamentals Value
Market Cap 87.72 Million
Num Shares 421 Million
EPS -1.20
Price-to-Earnings (P/E) Ratio -17.38
Price-to-Sales 165.15
Price-to-Book 3.94
PEG Ratio 0.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 24.30
Resistance 3 (R3) 24.27 23.08 23.73
Resistance 2 (R2) 23.08 22.20 23.10 23.53
Resistance 1 (R1) 21.97 21.66 22.53 22.00 23.34
Pivot Point 20.78 20.78 21.06 20.80 20.78
Support 1 (S1) 19.67 19.90 20.23 19.70 18.36
Support 2 (S2) 18.48 19.36 18.50 18.17
Support 3 (S3) 17.37 18.48 17.98
Support 4 (S4) 17.40